IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SALVI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.493
NA - Nord America 3.942
AS - Asia 1.875
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 16
SA - Sud America 16
OC - Oceania 12
Totale 10.371
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.894
PL - Polonia 1.382
DE - Germania 912
CN - Cina 817
UA - Ucraina 647
IT - Italia 460
SG - Singapore 404
FI - Finlandia 265
RU - Federazione Russa 211
GB - Regno Unito 186
IN - India 170
HK - Hong Kong 169
FR - Francia 156
TR - Turchia 140
IE - Irlanda 105
SE - Svezia 77
VN - Vietnam 75
BE - Belgio 47
ID - Indonesia 46
CA - Canada 45
EU - Europa 17
NL - Olanda 13
IR - Iran 12
AU - Australia 11
BR - Brasile 11
KR - Corea 10
CZ - Repubblica Ceca 7
TH - Thailandia 7
MU - Mauritius 6
RO - Romania 6
LY - Libia 5
BG - Bulgaria 3
ES - Italia 3
KZ - Kazakistan 3
LT - Lituania 3
BD - Bangladesh 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
PK - Pakistan 2
SA - Arabia Saudita 2
SD - Sudan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
IM - Isola di Man 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 10.371
Salva come PNG Salva come JPEG
Città #
Warsaw 1.382
Jacksonville 451
Fairfield 378
Chandler 361
Singapore 329
Woodbridge 311
Ann Arbor 276
Ashburn 258
Houston 202
Princeton 196
Helsinki 185
Wilmington 181
Brescia 167
Nanjing 167
Hong Kong 164
Cambridge 163
Beijing 155
Seattle 133
New York 131
Istanbul 107
Dublin 105
Dearborn 87
Dong Ket 70
Nanchang 53
Shenyang 49
Jinan 46
Brussels 45
Changsha 45
Jakarta 45
Moscow 43
Hebei 42
Des Moines 41
Shanghai 41
Milan 38
Lancaster 36
Munich 35
Pune 34
Tianjin 34
Jiaxing 32
Los Angeles 30
Kocaeli 24
San Diego 24
Kunming 23
San Francisco 19
Toronto 19
Nürnberg 18
North York 17
Hangzhou 16
Ningbo 16
Verona 15
Boardman 13
Zhengzhou 13
Romola 12
Falkenstein 10
Lappeenranta 10
London 10
Taizhou 9
Guangzhou 8
Haikou 8
Phoenix 8
Sundbyberg 8
Botucatu 7
Lanzhou 7
Magnago 7
Melbourne 7
Norwalk 7
Amsterdam 6
Augusta 6
Bari 6
Brno 6
Fuzhou 6
Ottawa 6
Santa Clara 6
Bologna 5
Borås 5
Castelnuovo Bozzente 5
Naples 5
Orange 5
Taiyuan 5
Brooklyn 4
Copertino 4
Hefei 4
Licata 4
Rockville 4
San Gregorio Magno 4
Suwon 4
Benghazi 3
Bhubaneswar 3
Daejeon 3
Frankfurt am Main 3
Hat Yai 3
Ho Chi Minh City 3
Indiana 3
Kilburn 3
Paris 3
Redwood City 3
Rosà 3
Sabz 3
San Paolo 3
São Paulo 3
Totale 7.125
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 317
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 283
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 277
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 220
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 211
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 196
Functional Role of microRNA-23b-3p in Cancer Biology 192
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 190
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 178
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 168
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 162
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 158
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 153
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 144
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 142
Biological Function of MicroRNA193a-3p in Health and Disease 142
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 139
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 138
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 138
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 133
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 130
microRNAs and human hepatocellular carcinoma 129
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 126
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 121
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 120
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 116
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 116
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 116
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 116
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 114
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 112
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 109
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 107
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 107
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 107
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 106
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 104
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 103
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 101
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 100
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 100
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 100
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 99
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 96
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 90
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 89
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 89
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 87
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 85
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 83
Urokinase and c-met are target of miR-23b in human cells. 79
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 79
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 78
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 75
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 74
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 73
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 73
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 72
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 72
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 72
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 71
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 71
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 70
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 69
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 69
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 68
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 68
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 68
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 67
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 67
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 66
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 66
RNA interference for urokinase gene in human hepatocellular carcinoma 66
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 66
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 65
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 65
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 64
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 64
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 64
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 63
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 63
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 63
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 62
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 60
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 60
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 58
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 58
The FN13 peptide inhibits human tumor cells invasion through the modulation of alphavbeta3 integrins organization and the inactivation of ILK pathway 58
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 57
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 56
DNA methylation variations in familial female and male breast cancer 56
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 55
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 54
Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. 53
Identificazione e validazione di target terapeutici nel cancro mediante RNAi. Tecnologia RNA interference per tumori solidi. 52
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 51
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 48
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib 48
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 47
The enrichment of miR-23b-3p, miR-126-3p and GAS5 in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the tumor growth of xenografts in zebrafish model 46
Totale 10.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.645 0 0 0 0 0 298 275 273 167 341 157 134
2020/20211.600 47 177 40 185 62 182 68 194 229 187 124 105
2021/2022847 48 155 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/2025972 37 50 49 384 216 236 0 0 0 0 0 0
Totale 10.613